111 Inc. (YI) |
|
6.3 0.1 (1.61%)
|
10-01 15:05 |
|
Open: |
6.19 |
Pre. Close: |
6.2 |
|
High:
|
6.34 |
Low:
|
6.16 |
|
Volume:
|
6,810 |
Market Cap:
|
523M |
|
|
|
|
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,350 full-time employees. The firm is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The firm mainly conducts its business in the domestic market. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.174 - 6.205 |
6.205 - 6.229 |
|
Low:
|
5.976 - 6.01 |
6.01 - 6.035 |
|
Close:
|
6.008 - 6.063 |
6.063 - 6.105 |
|
Technical analysis |
as of: 2020-10-01 2:11:41 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 7.76 One year: 9.06 |
| Support: |
Support1: 5.75 Support2: 5.20 |
| Resistance: |
Resistance1: 6.64 Resistance2: 7.76 |
| Pivot: |
5.99 |
| Moving Average: |
MA(5): 6.14 MA(20): 5.97
MA(100): 6.61  MA(250): 6.24 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.09 |
| Stochastic oscillator: |
%K(14,3): 67.39 %D(3): 64.37 |
| RSI: |
RSI(14): 54.17 |
| 52-week: |
High: 8.70 Low: 4.43 Change(%): 31.5 |
| Average Vol(K): |
3-Month: 10657 10-Days: 2114 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.YI has closed below upper band by 14.1%. Bollinger Bands are 2.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 01 Oct 2020
111 (NASDAQ:YI) Shareholders Booked A 29% Gain In The Last Year - Simply Wall St
Wed, 30 Sep 2020
111, Inc. Builds Digitally-enabled, Omni-channel Drug Commercialization Platform as Part of its Goal to Provide Full Life-cycle Healthcare Management Solutions for Patients - PRNewswire
Wed, 23 Sep 2020
What Is The Ownership Structure Like For 111, Inc. (NASDAQ:YI)? - Yahoo Finance
Tue, 15 Sep 2020
111, Inc. (NASDAQ:YI) is down -14.56% year-to-date, analysts forecast major price rally - Stocks Register
Mon, 14 Sep 2020
What is Forecast Price for 111 Inc - ADR (YI) Stock? - InvestorsObserver
Wed, 09 Sep 2020
How Does 111 Inc - ADR (YI) Stock Rank on Wall Street? - InvestorsObserver
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Pharmaceutical Retailers |
| Shares Out. (M) |
82 |
| Shares Float (M) |
24 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
5.57 |
|
Shares Short (K)
|
73 |
|
Shares Short P. Month (K)
|
77 |
Stock Financials |
|
EPS
|
-1.270 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
2.490 |
|
Profit Margin
|
-8.81 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-17.0 |
|
Return on Equity (ttm)
|
-61.5 |
|
Qtrly Rev. Growth
|
93.5 |
|
Gross Profit (p.s.)
|
0.439 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
-4.99 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.55 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
